カテゴリー： Transparency Market Research, 世界, 医療/バイオ

心房細動手術装置の世界市場2022～2031：手術別

◆英語タイトル：Atrial Fibrillation Surgery Devices Market (Procedure: Catheter Ablation and Surgical Ablation) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Transparency Market Researchが発行した調査報告書（TMR23MA019）◆商品コード：TMR23MA019
◆発行会社（リサーチ会社）：Transparency Market Research
◆発行日：2023年3月8日
◆ページ数：170
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥869,250見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,319,250見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,769,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社の当調査レポートでは、世界の心房細動手術装置市場規模が、2022年の21億ドルから2031年に70億ドルとなり、予測期間中に年平均成長率14%で拡大すると展望しています。本書は、心房細動手術装置の世界市場にフォーカスし、市場状況や今後の動向などをまとめた資料です。序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要インサイト、手術別（カテーテルアブレーション、外科的アブレーション）分析、エンドユーザー別（病院、専門センター、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の構成で掲載しています。また、市場参入企業として、Abbott Laboratories.、Biosense Webster, Inc.、Medtronic plc、Boston Scientific Corporation、CardioFocus, Inc.、AtriCure, Inc.、Osypka AG、Kardium, Inc.、Acutus Medical, Inc.、Koninklijke Philips N.V.などの情報が含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・主要インサイト
・世界の心房細動手術装置市場規模：手術別
- カテーテルアブレーションの市場規模
- 外科的アブレーションの市場規模
・世界の心房細動手術装置市場規模：エンドユーザー別
- 病院における市場規模
- 専門センターにおける市場規模
- 外来手術センターにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の心房細動手術装置市場規模：地域別
- 北米の心房細動手術装置市場規模
- ヨーロッパの心房細動手術装置市場規模
- アジア太平洋の心房細動手術装置市場規模
- 中南米の心房細動手術装置市場規模
- 中東・アフリカの心房細動手術装置市場規模
・競争状況

Atrial Fibrillation Surgery Devices Market – Scope of Report
TMR’s report on the global atrial fibrillation surgery devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global atrial fibrillation surgery devices market for the period 2017–2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global atrial fibrillation surgery devices market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the atrial fibrillation surgery devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global atrial fibrillation surgery devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global atrial fibrillation surgery devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global atrial fibrillation surgery devices market.

The report delves into the competitive landscape of the global atrial fibrillation surgery devices market. Key players operating in the global atrial fibrillation surgery devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global atrial fibrillation surgery devices market profiled in this report.

Key Questions Answered in Global Atrial Fibrillation Surgery Devices Market Report
• What is the sales/revenue generated by atrial fibrillation surgery devices across all regions during the forecast period?
• What are the opportunities in the global atrial fibrillation surgery devices market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Atrial Fibrillation Surgery Devices Market – Research Objectives and Research Approach
The comprehensive report on the global atrial fibrillation surgery devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global atrial fibrillation surgery devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global atrial fibrillation surgery devices market.

❖ レポートの目次 ❖

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Atrial Fibrillation Surgery Devices Market
4. Market Overview
    4.1. Introduction
        4.1.1. Procedure Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, 2017–2031
        4.4.1. Porter’s Five Forces Analysis
5. Key Insights
    5.1. Disease Prevalence & Incidence Rate Globally With Key Countries
    5.2. Technological Advancements
    5.3. Overview of Atrial Fibrillation
    5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, by Procedure
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Procedure, 2017–2031
        6.3.1. Catheter Ablation
            6.3.1.1. Radiofrequency Ablation
            6.3.1.2. Cryoablation
        6.3.2. Surgical Ablation
            6.3.2.1. Convergent Ablation
            6.3.2.2. Maze Ablation
    6.4. Market Attractiveness Analysis, by Procedure
7. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, by End-user
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by End-user, 2017–2031
        7.3.1. Hospitals
        7.3.2. Specialty Centers
        7.3.3. Ambulatory Surgical Centers
        7.3.4. Others
    7.4. Market Attractiveness Analysis, by End-user
8. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, by Region
    8.1. Key Findings
    8.2. Market Value Forecast, by Region
        8.2.1. North America
        8.2.2. Europe
        8.2.3. Asia Pacific
        8.2.4. Latin America
        8.2.5. Middle East & Africa
    8.3. Market Attractiveness Analysis, by Region
9. North America Atrial Fibrillation Surgery Devices Market Analysis and Forecast
    9.1. Introduction
        9.1.1. Key Findings
    9.2. Market Value Forecast, by Procedure, 2017–2031
        9.2.1. Catheter Ablation
            9.2.1.1. Radiofrequency Ablation
            9.2.1.2. Cryoablation
        9.2.2. Surgical Ablation
            9.2.2.1. Convergent Ablation
            9.2.2.2. Maze Ablation
    9.3. Market Value Forecast, by End-user, 2017–2031
        9.3.1. Hospitals
        9.3.2. Specialty Centers
        9.3.3. Ambulatory Surgical Centers
        9.3.4. Others
    9.4. Market Value Forecast, by Country, 2017–2031
        9.4.1. U.S.
        9.4.2. Canada
    9.5. Market Attractiveness Analysis
        9.5.1. By Procedure
        9.5.2. By End-user
        9.5.3. By Country
10. Europe Atrial Fibrillation Surgery Devices Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Procedure, 2017–2031
        10.2.1. Catheter Ablation
            10.2.1.1. Radiofrequency Ablation
            10.2.1.2. Cryoablation
        10.2.2. Surgical Ablation
            10.2.2.1. Convergent Ablation
            10.2.2.2. Maze Ablation
    10.3. Market Value Forecast, by End-user, 2017–2031
        10.3.1. Hospitals
        10.3.2. Specialty Centers
        10.3.3. Ambulatory Surgical Centers
        10.3.4. Others
    10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        10.4.1. Germany
        10.4.2. U.K.
        10.4.3. France
        10.4.4. Italy
        10.4.5. Spain
        10.4.6. Rest of Europe
    10.5. Market Attractiveness Analysis
        10.5.1. By Procedure
        10.5.2. By End-user
        10.5.3. By Country/Sub-region
11. Asia Pacific Atrial Fibrillation Surgery Devices Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Procedure, 2017–2031
        11.2.1. Catheter Ablation
            11.2.1.1. Radiofrequency Ablation
            11.2.1.2. Cryoablation
        11.2.2. Surgical Ablation
            11.2.2.1. Convergent Ablation
            11.2.2.2. Maze Ablation
    11.3. Market Value Forecast, by End-user, 2017–2031
        11.3.1. Hospitals
        11.3.2. Specialty Centers
        11.3.3. Ambulatory Surgical Centers
        11.3.4. Others
    11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.4.1. China
        11.4.2. Japan
        11.4.3. India
        11.4.4. Australia & New Zealand
        11.4.5. Rest of Asia Pacific
    11.5. Market Attractiveness Analysis
        11.5.1. By Procedure
        11.5.2. By End-user
        11.5.3. By Country/Sub-region
12. Latin America Atrial Fibrillation Surgery Devices Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Procedure, 2017–2031
        12.2.1. Catheter Ablation
            12.2.1.1. Radiofrequency Ablation
            12.2.1.2. Cryoablation
        12.2.2. Surgical Ablation
            12.2.2.1. Convergent Ablation
            12.2.2.2. Maze Ablation
    12.3. Market Value Forecast, by End-user, 2017–2031
        12.3.1. Hospitals
        12.3.2. Specialty Centers
        12.3.3. Ambulatory Surgical Centers
        12.3.4. Others
    12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.4.1. Brazil
        12.4.2. Mexico
        12.4.3. Rest of Latin America
    12.5. Market Attractiveness Analysis
        12.5.1. By Procedure
        12.5.2. By End-user
        12.5.3. By Country/Sub-region
13. Middle East & Africa Atrial Fibrillation Surgery Devices Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Procedure, 2017–2031
        13.2.1. Catheter Ablation
            13.2.1.1. Radiofrequency Ablation
            13.2.1.2. Cryoablation
        13.2.2. Surgical Ablation
            13.2.2.1. Convergent Ablation
            13.2.2.2. Maze Ablation
    13.3. Market Value Forecast, by End-user, 2017–2031
        13.3.1. Hospitals
        13.3.2. Specialty Centers
        13.3.3. Ambulatory Surgical Centers
        13.3.4. Others
    13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.4.1. GCC Countries
        13.4.2. South Africa
        13.4.3. Rest of Middle East & Africa
    13.5. Market Attractiveness Analysis
        13.5.1. By Procedure
        13.5.2. By End-user
        13.5.3. By Country/Sub-region
14. Competition Landscape
    14.1. Market Player – Competition Matrix (by tier and size of companies)
    14.2. Market Share Analysis, by Company (2022)
    14.3. Company Profiles
        14.3.1. AtriCure, Inc.
            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.1.2. Product Portfolio
            14.3.1.3. Financial Overview
            14.3.1.4. SWOT Analysis
            14.3.1.5. Strategic Overview
        14.3.2. CardioFocus, Inc.
            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.2.2. Product Portfolio
            14.3.2.3. Financial Overview
            14.3.2.4. SWOT Analysis
            14.3.2.5. Strategic Overview
        14.3.3. Abbott Laboratories
            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.3.2. Product Portfolio
            14.3.3.3. Financial Overview
            14.3.3.4. SWOT Analysis
            14.3.3.5. Strategic Overview
        14.3.4. Biosense Webster, Inc.
            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.4.2. Product Portfolio
            14.3.4.3. Financial Overview
            14.3.4.4. SWOT Analysis
            14.3.4.5. Strategic Overview
        14.3.5. Medtronic plc
            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.5.2. Product Portfolio
            14.3.5.3. Financial Overview
            14.3.5.4. SWOT Analysis
        14.3.6. Boston Scientific Corporation
            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.6.2. Product Portfolio
            14.3.6.3. Financial Overview
            14.3.6.4. SWOT Analysis
        14.3.7. Osypka AG
            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.7.2. Product Portfolio
            14.3.7.3. Financial Overview
            14.3.7.4. SWOT Analysis
        14.3.8. Kardium, Inc.
            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.8.2. Product Portfolio
            14.3.8.3. Financial Overview
            14.3.8.4. SWOT Analysis
        14.3.9. Acutus Medical, Inc.
            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.9.2. Product Portfolio
            14.3.9.3. Financial Overview
            14.3.9.4. SWOT Analysis
        14.3.10. Koninklijke Philips N.V.
            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.10.2. Product Portfolio
            14.3.10.3. Financial Overview
            14.3.10.4. SWOT Analysis
            14.3.10.5. Strategic Overview

List of Tables

Table 01: Global Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Procedure, 2017–2031

Table 02: Global Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 03: Global Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 04: North America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Procedure, 2017–2031

Table 05: North America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 06: North America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 07: Europe Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Procedure, 2017–2031

Table 08: Europe Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Asia Pacific Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Procedure, 2017–2031

Table 11: Asia Pacific Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 12: Asia Pacific Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 13: Latin America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Procedure, 2017–2031

Table 14: Latin America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 15: Latin America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 16: Middle East & Africa Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Procedure, 2017–2031

Table 17: Middle East & Africa Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 18: Middle East & Africa Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 心房細動手術装置の世界市場2022～2031：手術別(Atrial Fibrillation Surgery Devices Market (Procedure: Catheter Ablation and Surgical Ablation) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031)]についてメールでお問い合わせはこちらでお願いします。
グローバルリサーチ調査資料のイメージグローバルリサーチ調査資料のイメージ
◆関連リサーチレポート◆
  • 世界の心房細動アブレーションカテーテル市場予測2025年-2031年
  • 心臓内心エコー検査（ICE）の世界市場2023～2031：種類別、用途別
  • 世界の子宮鏡市場2023-2031：製品別（硬性ヒステロスコープ、軟性ヒステロスコープ）、用途別（手術、診断）
  • 世界の転移性骨疾患市場2023-2031：治療別（薬物療法、放射線療法、外科的介入、腫瘍切除療法）
  • 前立腺癌低侵襲手術の世界市場2022～2031：手術別

    • ◆H&Iグローバルリサーチのお客様（例）◆